Obesity, Infant
7
1
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Obesogenic Origins of Maternal and Child Metabolic Health Involving Dolutegravir
Maternal Characteristics Associated With Child Growth and Adiposity
Determine if Human Infant Weight Gain Can be Modulated to Prevent Obesity
Music and Child Health and Development
Health e-Baby: Trial to Reduce Obesity Risk Factors During the First 1,000 Days
Metabotyping of Overweight and Obese Children
The Effect of Baby-Led Weaning and Traditional Complementary Feeding Education on Infant Development